Results 81 to 90 of about 1,518,675 (340)

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

New England Journal of Medicine, 2021
Background Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy.
T. Shimabukuro, Shin Y. Kim, Tanya R. Myers, P. Moro, T. Oduyebo, L. Panagiotakopoulos, P. Marquez, C. Olson, Ruiling Liu, Karen T Chang, S. Ellington, V. Burkel, A. Smoots, C. J. Green, C. Licata, Bicheng Zhang, M. Alimchandani, A. Mba-Jonas, S. Martin, J. Gee, D. Meaney-Delman   +20 more
semanticscholar   +1 more source

Confidence, Acceptance and Willingness to Pay for the COVID-19 Vaccine among Migrants in Shanghai, China: A Cross-Sectional Study

Vaccines, 2021
Understanding the public’s attitude towards COVID-19 vaccination and their acceptance could help facilitate the COVID-19 rollout. This study aimed to assess the acceptance and willingness to pay (WTP) for the COVID-19 vaccine among migrants in Shanghai ...
Kaiyi Han, Mark R. Francis, Ruiyun Zhang, Qian Wang, Aichen Xia, Linyao Lu, Bingyi Yang, Zhiyuan Hou   +7 more
doaj   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

COVID‐19 vaccine hesitancy: Race/ethnicity, trust, and fear

Clinical and Translational Science, 2021
Understanding and minimizing coronavirus disease 2019 (COVID‐19) vaccine hesitancy is critical to population health and minimizing health inequities, which continue to be brought into stark relief by the pandemic.
Don E. Willis, Jennifer A. Andersen, Keneshia Bryant‐Moore, James P. Selig, Christopher R. Long, Holly C. Felix, Geoffrey M. Curran, Pearl A. McElfish   +7 more
doaj   +1 more source

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

, 2021
Background A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this ...
Minassian, Angela M, Fuskova, Michelle, Green, Christopher A, Aley, Parvinder K, Bibi, Sagida, al., Et, Snape, Matthew, Angus, Brian, Plested, Emma, Kerridge, Simon, Hill, Adrian, Robinson, Hannah, Lambe, Teresa, Greenland, Melanie, Bonsall, David, Gilbert, Sarah, Ramasamy, Maheshi, Pollard, Andrew J, Dold, Christina, Voysey, Merryn, Green, Catherine M, Song, Rinn, Marchevsky, Natalie G, Golubchik, Tanya, Clutterbuck, Elizabeth A, Mujadidi, Yama F, Folegatti, Pedro M, Feng, Shuo, Emary, Katherine RW, Cicconi, Paola, Flaxman, Amy L, Douglas, Alexander D, Ewer, Katie J, Phillips, Daniel J, Jenkin, Daniel   +34 more
core   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study

BMC Infectious Diseases, 2021
Background Coronavirus disease 2019 (COVID-19) vaccination has raised concerns about vaccine hesitancy in general and COVID-19 vaccine hesitancy in particular.
Rehab H. El-Sokkary, Omnia S. El Seifi, Hebatallah M. Hassan, Eman M. Mortada, Maiada K. Hashem, Mohamed Rabie Mohamed Ali Gadelrab, Rehab M. Elsaid Tash   +6 more
doaj   +1 more source

Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China

PLoS Neglected Tropical Diseases, 2020
Background This study attempts to understand coronavirus disease 2019 (COVID-19) vaccine demand and hesitancy by assessing the public’s vaccination intention and willingness-to-pay (WTP).
Yulan Lin, Zhijian Hu, Qinjian Zhao, Haridah Alias, M. Danaee, L. Wong   +5 more
semanticscholar   +1 more source

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

New England Journal of Medicine, 2021
Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype ...
P. Heath, E. Galiza, D. Baxter, M. Boffito, D. Browne, F. Burns, D. Chadwick, R. Clark, C. Cosgrove, J. Galloway, A. Goodman, Amardeep Heer, A. Higham, Shalini Iyengar, A. Jamal, Christopher Jeanes, P. Kalra, Christina Kyriakidou, D. McAuley, Agnieszka Meyrick, A. Minassian, J. Minton, P. Moore, Imrozia Munsoor, Helen Nicholls, O. Osanlou, J. Packham, Carol H. Pretswell, Alberto San Francisco Ramos, D. Saralaya, Ray Sheridan, Richard Smith, R. Soiza, P. Swift, E. Thomson, J. Turner, M. E. Viljoen, G. Albert, I. Cho, F. Dubovsky, G. Glenn, J. Rivers, A. Robertson, Kathy Smith, S. Toback   +44 more
semanticscholar   +1 more source

Adjuvants for COVID-19 Vaccines

Vaccines, 2023
In recent decades, the improvement of traditional vaccines has meant that we have moved from inactivated whole virus vaccines, which provoke a moderate immune response but notable adverse effects, to much more processed vaccines such as protein subunit vaccines, which despite being less immunogenic have better tolerability profiles.
Javier Castrodeza-Sanz, Iván Sanz-Muñoz, Jose M. Eiros   +2 more
openaire   +3 more sources